“Retrospective Comparison of Efficacy and Safety of Basiliximab and Antithymocyte Globulin in Kidney Transplant Recipients”. 2021. Khartoum Journal of Pharmaceutical Sciences 1 (1). https://doi.org/10.53332/kjps.v1i1.40.